Universe Pharmaceuticals Closes Public Offering
Ticker: UPC · Form: 6-K · Filed: Jul 18, 2024 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $0.01875, $1.25, $25 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: public-offering, equity-raise, pharmaceuticals
TL;DR
Universe Pharma closed its share offering on July 15, 2024, selling 20M shares at $1.25 each.
AI Summary
Universe Pharmaceuticals INC announced the closing of its self-underwritten public offering on July 15, 2024. The company sold 20,000,000 ordinary shares at a price of $1.25 per share, raising an unspecified amount of capital. The offering was for ordinary shares with a par value of $0.01875 each.
Why It Matters
The successful closing of this public offering indicates investor confidence and provides the company with capital, potentially for expansion or operational needs.
Risk Assessment
Risk Level: medium — The filing details a public offering, which can impact share price and dilution, but the exact amount raised is not specified, leaving some uncertainty.
Key Numbers
- 20,000,000 — Ordinary Shares Sold (Represents the volume of the public offering.)
- $1.25 — Price Per Share (The price at which each ordinary share was offered.)
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 6-K report and issuer of the shares
- July 15, 2024 (date) — Date of the closing of the public offering
- 20,000,000 (dollar_amount) — Number of ordinary shares sold in the offering
- $1.25 (dollar_amount) — Price per ordinary share in the offering
- $0.01875 (dollar_amount) — Par value per ordinary share
FAQ
What was the total amount of capital raised from the public offering?
The filing states that 20,000,000 ordinary shares were sold at $1.25 per share, but the total amount raised is not explicitly stated in the provided text.
What is the par value of the ordinary shares offered?
The par value of the ordinary shares is $0.01875 per share.
When did Universe Pharmaceuticals INC close its public offering?
The company closed its public offering on July 15, 2024.
What type of company is Universe Pharmaceuticals INC?
Universe Pharmaceuticals INC is a Cayman Islands company operating in the Pharmaceutical Preparations industry.
Where is Universe Pharmaceuticals INC's principal executive office located?
The principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
Filing Stats: 256 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2024-07-18 16:05:17
Key Financial Figures
- $0.01875 — f 20,000,000 ordinary shares, par value $0.01875 per share (the “Ordinary Shares&r
- $1.25 — o;). The Ordinary Shares were priced at $1.25 per share. The Company raised a total o
- $25 million — er share. The Company raised a total of $25 million through this Offering, before deducting
Filing Documents
- ea0209657-6k_universe.htm (6-K) — 9KB
- 0001213900-24-062550.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Universe Pharmaceuticals INC. Date: July 18, 2024 By: /s/ Gang Lai Gang Lai Chief Executive Officer 2